Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation

被引:343
作者
Sabapathy, K
Hochedlinger, K
Nam, SY
Bauer, A
Karin, M
Wagner, EF
机构
[1] Res Inst Mol Pathol, A-1030 Vienna, Austria
[2] Natl Canc Ctr, Singapore 169610, Singapore
[3] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct,Canc Ctr, La Jolla, CA 92093 USA
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
D O I
10.1016/j.molcel.2004.08.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Different c-Jun N-terminal kinases (JNKs) are activated by a plethora of signals and phosphorylate substrates such as c-Jun, which is required for efficient cell cycle progression. Although JNK1 and JNK2 were shown to differentially regulate fibroblast proliferation, the underlying mechanistic basis remains unclear. We found that Jnk2(-/-) fibroblasts exit G1 and enter S phase earlier than wild-type counterparts, while Jnk1(-/-) cells show the inverse phenotype. Moreover, Jnk2(-/-) erythroblasts also exhibit a proliferative advantage. JNK2 deficiency results in elevated c-Jun phosphorylation and stability, whereas the absence of JNK1 reduces c-Jun phosphorylation and stability. Re-expression of JNK2 in Jnk2(-/-) cells reverses the JNK2 null phenotype, whereas ectopic expression of JNK1 augments it. JNK2 is preferentially bound to c-Jun in unstimulated cells, thereby contributing to c-Jun degradation. In contrast, JNK1 becomes the major c-Jun interacting kinase after cell stimulation. These data provide mechanistic insights into the distinct roles of different JNK isoforms.
引用
收藏
页码:713 / 725
页数:13
相关论文
共 52 条
[51]   Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2 [J].
Yang, DD ;
Conze, D ;
Whitmarsh, AJ ;
Barrett, T ;
Davis, RJ ;
Rincón, M ;
Flavell, RA .
IMMUNITY, 1998, 9 (04) :575-585
[52]   High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model [J].
Zoumpourlis, V ;
Papassava, P ;
Linardopoulos, S ;
Gillespie, D ;
Balmain, A ;
Pintzas, A .
ONCOGENE, 2000, 19 (35) :4011-4021